NCI Division of Cancer Prevention shared on LinkedIn:
“Congratulations to DCP’s Director Dr. Phil Castle who was recently appointed as the National Cancer Institute (NCI)’s Associate Director for Prevention.
In addition to directing the Division of Cancer Prevention, Dr. Castle will convene and coordinate trans-NCI initiatives and activities to identify, evaluate, and translate strategies that prevent cancer or halt its progression.
As Dr. Castle says,
‘The best cancer is the one you never get.'”
About Dr. Philip E. Castle
Dr. Philip E. Castle, Ph.D., M.P.H., is an internationally recognized expert in cervical cancer prevention. His research focuses on human papillomavirus (HPV) vaccination, cervical cancer screening, the natural history of cervical precancer and cancer, and the development and validation of new technologies for cancer prevention. His work has contributed to U.S. cervical cancer screening and management guidelines, particularly the implementation of primary HPV testing.
Dr. Castle first joined the National Cancer Institute (NCI) in 2000 as a Cancer Prevention Fellow. He later served as Executive Director and Chief Scientific Officer of ASCCP and as a tenured professor at Albert Einstein College of Medicine. He has served as Director of the NCI Division of Cancer Prevention and was appointed NCI Associate Director for Prevention in November 2026.
You can also read: Anthony Letai Announces Dr. Phil Castle’s Appointment as Associate Director for Prevention at NCI.”